Although pancreatic cancers are resistant to certain inhibitors of the VEGF pathway, we found that the proliferation and migration of pancreatic cancer cells were inhibited by apatinib in a concentration-dependent manner. Here, VEGFA is linked to pancreatic neoplasm.